The book covers the latest breakthroughs in nanotechnology applied to cancer research. It examines how biomarkers and ligands revolutionize cancer diagnosis and treatment, providing new avenues for personalized medicine and targeted therapies. By bridging disciplines and offering a thorough examination of current and future trends, it equips readers with the knowledge to advance cancer care and improve patient outcomes.
The chapters delve into key concepts such as the design and synthesis of ligand-functionalized nanoparticles, the role of biomarkers in cancer prognosis, and the integration of nanotechnology in personalized medicine. Expert contributors provide insights into the use of nanoparticles for imaging and drug delivery, highlighting the potential of nanotechnology to enhance therapeutic efficacy while minimizing side effects.
The book is targeted towards oncologists, dermatologists, researchers specializing in cancer treatment, as well as medical students and pharmaceutical scientists. The book aligns with the core curriculum and examination requirements, making it a suitable tool for students and trainees.
